Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases Journal Article

  


Authors: Yang, J. C.; Wexler, L. H.; Meyers, P. A.; Happersett, L.; La Quaglia, M. P.; Wolden, S. L.
Article Title: Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases
Abstract: Background: We examined patterns of failure in pediatric patients with thoracic sarcoma and pulmonary metastases treated with intensity-modulated radiation therapy with dose-painting (DP-IMRT). Procedure: Eleven pediatric patients, five with Ewing sarcoma family tumors (ESFT) and six with rhabdomyosarcoma (RMS), with primary thoracic tumors and pulmonary metastases underwent DP-IMRT with chemotherapy for definitive treatment. Eight patients also underwent surgery. Median time to RT was 21 (15-31) weeks. Nine patients received 45-50.4-Gy in 1.8Gy fractions to the primary tumor (n=3) or post-operative tumor bed (n=6). Two patients ≤4 years received 12Gy intraoperative radiation therapy and 30.6-36Gy IMRT postoperatively to the tumor bed. All patients received 14-16.8Gy in 0.54-0.88Gy fractions to the whole lungs (n=6) or hemithorax (n=5) using dose-painting technique. A representative case was re-planned with IMRT plus standard AP/PA whole lung irradiation (WLI) for dosimetric comparison. Results: With 27-month median follow-up, 3-year pulmonary relapse-free survival in all patients was 61%: 80% for RMS and 40% for ESFT. Five patients (4 ESFT and 1 RMS) experienced pulmonary relapse at median 16 (9-41) months. There were no local failures. Our representative case demonstrated more homogeneous target volume coverage of the whole lungs and decreased mean dose to esophagus (15%), heart (31%), spinal cord (15%), and liver (19%) with DP-IMRT. Conclusions: The treatment of children with a primary thoracic tumor and pulmonary metastases poses a significant challenge. DP-IMRT is one solution to this technical problem. Initial data from this small series suggest DP-IMRT is feasible and produces superior sparing of critical normal tissues. Pediatr Blood Cancer 2013;60:1616-1620. © 2013 Wiley Periodicals, Inc.
Keywords: adolescent; adult; cancer chemotherapy; child; clinical article; preschool child; school child; child, preschool; disease-free survival; primary tumor; survival rate; retrospective studies; intensity modulated radiation therapy; radiation dose; follow up; follow-up studies; lung neoplasms; childhood cancer; ewing sarcoma; sarcoma; thoracic neoplasms; lung metastasis; liver; radiotherapy, intensity-modulated; spinal cord; lung; neoplasm metastasis; rhabdomyosarcoma; thorax tumor; heart; esophagus; intraoperative radiotherapy; recurrence free survival; pulmonary metastases; sarcoma, ewing; ewing sarcoma family tumors; intensity-modulated radiotherapy with dose-painting; pediatric sarcomas
Journal Title: Pediatric Blood and Cancer
Volume: 60
Issue: 10
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2013-10-01
Start Page: 1616
End Page: 1620
Language: English
DOI: 10.1002/pbc.24502
PROVIDER: scopus
PUBMED: 23765910
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84881486154&partnerID=40&md5=c4e3cc4fa6768232afe60947259a3f8d
Notes: --- - "Export Date: 4 September 2013" - "CODEN: PBCEA" - "Source: Scopus"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael P La Quaglia
    411 La Quaglia
  2. Suzanne L Wolden
    560 Wolden
  3. Leonard H Wexler
    191 Wexler
  4. Laura Happersett
    89 Happersett
  5. Paul Meyers
    311 Meyers
  6. Joanna C Yang
    41 Yang
Related MSK Work